Tuesday, Dec 01st

Last update04:10:06 AM GMT

You are here News Health FDA ignored debris in syringes

FDA ignored debris in syringes

E-mail Print PDF

Months before an Angier company shipped deadly bacteria-tainted drugs, the federal Food and Drug Administration received numerous complaints about sediment and debris in the medicine.

The FDA received reports about AM2PAT as early as 2005, but not until December 2007 did the agency issue recall notices to pull the drugs off the market.

Two men pleaded guilty in U.S. District Court this week for their roles in the scheme, which involved falsifying documents to make it appear that proper sterility tests had been conducted. The company’s president, Dushyant Patel, faces 10 charges, but he has not been arrested.


Most Recent Related Stories...

Despite promise, Turing pharmaceuticals opts to keep list price of Daraprim high

Deraprim- Despite a promise from its chief executive two months ago, Turing Pharmaceuticals said Wednesday it...

Federal Court: Restrictive WI Abortion Law Is Unconstitutional, Endangers Women's Health

Wisc. abortion law unconstitutionalA Wisconsin law that requires abortion providers to get admitting privileges at nearby hospitals is unconstitutional,...

Frank Gifford suffered from brain disease CTE, family says

Frank Gifford had CTEPro Football Hall of Famer Frank Gifford, who died this past summer of natural causes, suffered...

CDC says E. coli outbreak linked to Chipotle restaurants now involves six states

Chipolte E.coli outbreak is in six statesAn outbreak of E. coli that was first reported in the Pacific Northwest and linked to...
America's # 1 Enemy
Tee Shirt
& Help Support!
TVNL Tee Shirt
Conserve our Planet
& Help Support!
Get your 9/11 & Media
Deception Dollars
& Help Support!
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!